229 related articles for article (PubMed ID: 18694962)
1. Serum-induced phosphorylation of the serum response factor coactivator MKL1 by the extracellular signal-regulated kinase 1/2 pathway inhibits its nuclear localization.
Muehlich S; Wang R; Lee SM; Lewis TC; Dai C; Prywes R
Mol Cell Biol; 2008 Oct; 28(20):6302-13. PubMed ID: 18694962
[TBL] [Abstract][Full Text] [Related]
2. Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes.
Cen B; Selvaraj A; Burgess RC; Hitzler JK; Ma Z; Morris SW; Prywes R
Mol Cell Biol; 2003 Sep; 23(18):6597-608. PubMed ID: 12944485
[TBL] [Abstract][Full Text] [Related]
3. Induction of megakaryocyte differentiation drives nuclear accumulation and transcriptional function of MKL1 via actin polymerization and RhoA activation.
Smith EC; Teixeira AM; Chen RC; Wang L; Gao Y; Hahn KL; Krause DS
Blood; 2013 Feb; 121(7):1094-101. PubMed ID: 23243284
[TBL] [Abstract][Full Text] [Related]
4. Myocardin/MKL family of SRF coactivators: key regulators of immediate early and muscle specific gene expression.
Cen B; Selvaraj A; Prywes R
J Cell Biochem; 2004 Sep; 93(1):74-82. PubMed ID: 15352164
[TBL] [Abstract][Full Text] [Related]
5. Megakaryoblastic leukemia-1/2, a transcriptional co-activator of serum response factor, is required for skeletal myogenic differentiation.
Selvaraj A; Prywes R
J Biol Chem; 2003 Oct; 278(43):41977-87. PubMed ID: 14565952
[TBL] [Abstract][Full Text] [Related]
6. Actin dynamics control SRF activity by regulation of its coactivator MAL.
Miralles F; Posern G; Zaromytidou AI; Treisman R
Cell; 2003 May; 113(3):329-42. PubMed ID: 12732141
[TBL] [Abstract][Full Text] [Related]
7. Mitogen-activated protein kinase 14 is a novel negative regulatory switch for the vascular smooth muscle cell contractile gene program.
Long X; Cowan SL; Miano JM
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):378-86. PubMed ID: 23175675
[TBL] [Abstract][Full Text] [Related]
8. Mutant actins that stabilise F-actin use distinct mechanisms to activate the SRF coactivator MAL.
Posern G; Miralles F; Guettler S; Treisman R
EMBO J; 2004 Oct; 23(20):3973-83. PubMed ID: 15385960
[TBL] [Abstract][Full Text] [Related]
9. Megakaryoblastic leukemia factor-1 transduces cytoskeletal signals and induces smooth muscle cell differentiation from undifferentiated embryonic stem cells.
Du KL; Chen M; Li J; Lepore JJ; Mericko P; Parmacek MS
J Biol Chem; 2004 Apr; 279(17):17578-86. PubMed ID: 14970199
[TBL] [Abstract][Full Text] [Related]
10. Role of megakaryoblastic acute leukemia-1 in ERK1/2-dependent stimulation of serum response factor-driven transcription by BDNF or increased synaptic activity.
Kalita K; Kharebava G; Zheng JJ; Hetman M
J Neurosci; 2006 Sep; 26(39):10020-32. PubMed ID: 17005865
[TBL] [Abstract][Full Text] [Related]
11. OTT-MAL is a deregulated activator of serum response factor-dependent gene expression.
Descot A; Rex-Haffner M; Courtois G; Bluteau D; Menssen A; Mercher T; Bernard OA; Treisman R; Posern G
Mol Cell Biol; 2008 Oct; 28(20):6171-81. PubMed ID: 18710951
[TBL] [Abstract][Full Text] [Related]
12. Delayed stress fiber formation mediates pulmonary myofibroblast differentiation in response to TGF-β.
Sandbo N; Lau A; Kach J; Ngam C; Yau D; Dulin NO
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L656-66. PubMed ID: 21856814
[TBL] [Abstract][Full Text] [Related]
13. Filamin A interacts with the coactivator MKL1 to promote the activity of the transcription factor SRF and cell migration.
Kircher P; Hermanns C; Nossek M; Drexler MK; Grosse R; Fischer M; Sarikas A; Penkava J; Lewis T; Prywes R; Gudermann T; Muehlich S
Sci Signal; 2015 Nov; 8(402):ra112. PubMed ID: 26554816
[TBL] [Abstract][Full Text] [Related]
14. Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction.
Huang X; Yang N; Fiore VF; Barker TH; Sun Y; Morris SW; Ding Q; Thannickal VJ; Zhou Y
Am J Respir Cell Mol Biol; 2012 Sep; 47(3):340-8. PubMed ID: 22461426
[TBL] [Abstract][Full Text] [Related]
15. Transient α-helices in the disordered RPEL motifs of the serum response factor coactivator MKL1.
Mizuguchi M; Fuju T; Obita T; Ishikawa M; Tsuda M; Tabuchi A
Sci Rep; 2014 Jun; 4():5224. PubMed ID: 24909411
[TBL] [Abstract][Full Text] [Related]
16. Redox modification of nuclear actin by MICAL-2 regulates SRF signaling.
Lundquist MR; Storaska AJ; Liu TC; Larsen SD; Evans T; Neubig RR; Jaffrey SR
Cell; 2014 Jan; 156(3):563-76. PubMed ID: 24440334
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional activity of megakaryoblastic leukemia 1 (MKL1) is repressed by SUMO modification.
Nakagawa K; Kuzumaki N
Genes Cells; 2005 Aug; 10(8):835-50. PubMed ID: 16098147
[TBL] [Abstract][Full Text] [Related]
18. The actin/MKL1 signalling pathway influences cell growth and gene expression through large-scale chromatin reorganization and histone post-translational modifications.
Flouriot G; Huet G; Demay F; Pakdel F; Boujrad N; Michel D
Biochem J; 2014 Jul; 461(2):257-68. PubMed ID: 24762104
[TBL] [Abstract][Full Text] [Related]
19. Activation and repression of cellular immediate early genes by serum response factor cofactors.
Lee SM; Vasishtha M; Prywes R
J Biol Chem; 2010 Jul; 285(29):22036-49. PubMed ID: 20466732
[TBL] [Abstract][Full Text] [Related]
20. Control of myofibroblast differentiation by microtubule dynamics through a regulated localization of mDia2.
Sandbo N; Ngam C; Torr E; Kregel S; Kach J; Dulin N
J Biol Chem; 2013 May; 288(22):15466-73. PubMed ID: 23580645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
